Doctor profile · Federal record

Dr. Paul Schulman, M.D.

Rheumatology Physician (CMS: Rheumatology) · Smithtown, NY

  • NPI 1639165541
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 43 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
315 Middle Country RD
Smithtown, NY 117872817
(631) 360-7778
fax (631) 979-1609

Credentials & registration

NPPES · NUCC
NPI registered
September 2005 — 21 yrs on file
Profile last updated
May 19, 2014
Year of graduation
1983 — 43 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
New York #161423
Medicaid
NY #01835249

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1639165541. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
122,473
Distinct HCPCS
10
Medicare allowed
$1,969,566
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 47,800 21 $5
J3262 Injection, tocilizumab, 1 mg 29,229 18 $6
J0897 Injection, denosumab, 1 mg 12,240 126 $23
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 11,150 53 $42
J1602 Injection, golimumab, 1 mg, for intravenous use 10,751 30 $13
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,510 23 $33
J9312 Injection, rituximab, 10 mg 2,100 17 $80
J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg 1,560 18 $17
99214 Established patient office or other outpatient visit, 30-39 minutes 1,319 610 $149
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 611 92 $1

In context: peer comparison

Among 4 peers in this city , average services per provider: 3,320. This provider delivers 37× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,557
Transactions
154
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen Inc. 33 $723.52
ABBVIE INC. 19 $499.96
Janssen Biotech, Inc. 21 $465.11
PFIZER INC. 19 $346.69
Lilly USA, LLC 10 $319.89
UCB, Inc. 15 $276.23
Boehringer Ingelheim Pharmaceuticals, Inc. 8 $212.43
GlaxoSmithKline, LLC. 8 $162.57
Novartis Pharmaceuticals Corporation 6 $119.62
Aurinia Pharma U.S., Inc. 4 $68.49
Sandoz Inc. 3 $63.52
Kiniksa Pharmaceuticals International, plc 2 $44.82
Radius Health, Inc. 2 $43.97
Ferring Pharmaceuticals Inc. 2 $43.82
Genentech USA, Inc. 2 $35.00

By nature of payment

Food and Beverage
$3,552
Education
$6

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
3,097
Patients
867
Total drug cost
$92,696
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 391 101 $13,825
Hydroxychloroquine Sulfate Generic 352 93 $17,993
Prednisone Generic 350 96 $3,006
Celecoxib Generic 343 115 $18,497
Gabapentin Generic 229 70 $3,377
Duloxetine Hcl Generic 206 57 $9,221
Tramadol Hcl Generic 194 45 $1,472
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 186 32 $3,585
Pregabalin Generic 169 35 $10,798
Cyclobenzaprine Hcl Generic 146 46 $3,231

Frequently asked questions

Auto-generated from federal data
What is Dr. Paul Schulman's medical specialty?
Dr. Paul Schulman practices Rheumatology Physician in Smithtown, NY.
Where does Dr. Paul Schulman practice?
Dr. Paul Schulman practices at 315 Middle Country RD, Smithtown, NY 117872817. Office phone: 6313607778.
What is Dr. Paul Schulman's NPI?
Dr. Paul Schulman's National Provider Identifier (NPI) is 1639165541, issued by NPPES.
Does Dr. Paul Schulman accept Medicare assignment?
Yes. Dr. Paul Schulman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Paul Schulman commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.